HuGE Literature Finder
Records
1
-
17
| Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia. Blood science (Baltimore, Md.) 2023 2 5 (1): 32-38. Hao Qishan, Song Yang, Fang Qiuyun, Lin Yani, Chen Long, Wang Xiaodan, Zhang Ping, Wang Zhe, Gong Xiaoyuan, Liu Kaiqi, Li Qinghua, Tian Zheng, Wang Min, Wang Jianxiang, Mi Yingcha |
| Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology 2022 12 91 (1): 77-87. Li Miao, Kong Xiao-Yan, Wang Shu-M |
| Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib. Frontiers in oncology 2021 11 672287. Loscocco Federica, Visani Giuseppe, Ruzzo Annamaria, Bagaloni Irene, Fuligni Fabio, Galimberti Sara, Di Paolo Antonello, Stagno Fabio, Pregno Patrizia, Annunziata Mario, Gozzini Antonella, Barulli Sara, Gabucci Elisa, Magnani Mauro, Isidori Alessand |
| Association of ABCC2 with levels and toxicity of methotrexate in Malaysian Childhood Acute Lymphoblastic Leukemia (ALL). Pediatric hematology and oncology 2019 Dec 1-13. Razali Rizal Husaini, Noorizhab Mohd Nur Fakhruzzaman, Jamari Hisyam, James Richard Johari, Teh Kok Hoi, Ibrahim Hishamshah Mohd, Teh Lay Kek, Salleh Mohd Za |
| The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients. Archives of medical science : AMS 2018 Oct 14 (6): 1416-1423. Belohlavkova Petra, Vrbacky Filip, Voglova Jaroslava, Racil Zdenek, Zackova Daniela, Hrochova Katerina, Malakova Jana, Mayer Jiri, Zak Pav |
| Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study. Pharmacogenetics and genomics 2018 Aug . Zgheib Nathalie K, Ghanem Khaled M, Tamim Hani, Aridi Carole, Shahine Randa, Tarek Nidale, Saab Raya, Abboud Miguel R, El-Solh Hassan, Muwakkit Samar |
| Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma. BMC cancer 2018 Jul 18 (1): 704. Sági Judit C, Egyed Bálint, Kelemen Andrea, Kutszegi Nóra, Hegyi Márta, Gézsi András, Herlitschke Martina Ayaka, Rzepiel Andrea, Fodor Lili E, Ottóffy Gábor, Kovács Gábor T, Erdélyi Dániel J, Szalai Csaba, Semsei Ágnes |
| Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia. Pharmacogenomics 2016 05 17 (7): 731-41. Lopez-Lopez Elixabet, Gutierrez-Camino Angela, Astigarraga Itziar, Navajas Aurora, Echebarria-Barona Aizpea, Garcia-Miguel Purificacion, Garcia de Andoin Nagore, Lobo Carmen, Guerra-Merino Isabel, Martin-Guerrero Idoia, Garcia-Orad Afri |
| Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenetics and genomics 2014 Aug 24 (8): 387-96. Zgheib Nathalie K, Akra-Ismail Maya, Aridi Carol, Mahfouz Rami, Abboud Miguel R, Solh Hassan, Muwakkit Samar |
| Association of -24CT, 1249GA, and 3972CT ABCC2 gene polymorphisms with methotrexate serum levels and toxic side effects in children with acute lymphoblastic leukemia. Pediatric hematology and oncology 2014 Mar 31 (2): 169-77. Sharifi Mohamad Jafar, Bahoush Gholamreza, Zaker Farhad, Ansari Shahla, Rafsanjani Khadijeh Arjmandi, Sharafi Heid |
| Association of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia. PloS one 2014 9 (1): e82681. Liu Yan, Yin You, Sheng Qi, Lu Xiaotong, Wang Fang, Lin Zhiyan, Tian Huaiping, Xu Ajing, Zhang Ji |
| Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy. International journal of hematology 2013 Dec 98 (6): 702-7. Yanagimachi Masakatsu, Goto Hiroaki, Kaneko Tetsuji, Naruto Takuya, Sasaki Koji, Takeuchi Masanobu, Tanoshima Reo, Kato Hiromi, Yokosuka Tomoko, Kajiwara Ryosuke, Fujii Hisaki, Tanaka Fumiko, Goto Shoko, Takahashi Hiroyuki, Mori Masaaki, Kai Sumio, Yokota Shump |
| Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia. Pharmacogenetics and genomics 2013 Feb 23 (2): 53-61. Lopez-Lopez Elixabet, Ballesteros Javier, Piñan Maria A, Sanchez de Toledo José, Garcia de Andoin Nagore, Garcia-Miguel Purificacion, Navajas Aurora, Garcia-Orad Afri |
| A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk. International journal of cancer. Journal international du cancer 2012 Aug 131 (4): 803-12. Campa Daniele, Butterbach Katja, Slager Susan L, Skibola Christine F, de Sanjosé Silvia, Benavente Yolanda, Becker Nikolaus, Foretova Lenka, Maynadie Marc, Cocco Pierluigi, Staines Anthony, Kaaks Rudolf, Boffetta Paolo, Brennan Paul, Conde Lucia, Bracci Paige M, Caporaso Neil E, Strom Sara S, Camp Nicola J, Cerhan James R, Consortium Gec, Canzian Federico, Nieters Alexand |
| Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia. Journal of human genetics 2010 Nov 55 (11): 731-7. Takahashi Naoto, Miura Masatomo, Scott Stuart A, Kagaya Hideaki, Kameoka Yoshihiro, Tagawa Hiroyuki, Saitoh Hirobumi, Fujishima Naohito, Yoshioka Tomoko, Hirokawa Makoto, Sawada Kenic |
| Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition. PloS one 2010 5 (11): e13792. Ni Wenjun, Ji Jia, Dai Zunyan, Papp Audrey, Johnson Amy J, Ahn Sunjoo, Farley Katherine L, Lin Thomas S, Dalton James T, Li Xiaobai, Jarjoura David, Byrd John C, Sadee Wolfgang, Grever Michael R, Phelps Mitch |
| High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations. Clinical pharmacology and therapeutics 2006 Nov 80 (5): 468-76. Rau Thomas, Erney Birgit, Göres Ralf, Eschenhagen Thomas, Beck Jörn, Langer Thorst |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: